United American Healthcare Corp (UAHC) fair value: what the stock is really worth
As of Oct 29, 2026: fair value (intrinsic value) of United American Healthcare Corp stock $0.02, price $0.02, upside +27.0%, quality 62 out of 100. Rating: undervalued. Calculated from audited financials with 8 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range $0.0069 – $0.0980 · fair‑value band $0.0204 – $0.0261 · the $0.0180 price screens below the $0.0229 fair value. 2 fiscal years are left out: there the valuation rested on only a fraction of the usual models. As of Nov 7, 2026.
Follow United American Healthcare in your weekly email
Every Wednesday you see whether United American Healthcare is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
United American Healthcare Corporation, through its subsidiaries, provides comprehensive management and consulting services to managed care organizations and other administrative services related to employee welfare and health benefit plans.
Show moreShow less
The company was incorporated in 1983 and is based in Chicago, Illinois.
Stock analysis
United American Healthcare Corp (UAHC) currently trades at $0.0180, while our model-based Fair Value estimate is $0.0229, implying the stock looks roughly 21% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of $0.1000 per share, and 7 of the 8 models we run sit above the $0.0180 price.
Bear case: the Economic Profit group reads lowest at $0.0100, and 1 of the 8 models stay below the price. Data coverage for this calculation is low.
Scenario range: $0.0204 (bear) to $0.0261 (bull), the price of $0.0180 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 62/100 (solid quality), in the Real Estate sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
United American Healthcare Corp reported revenue of $10.7M in FY2017 versus $6.5M in FY2013, a compound +13.4%/yr. Reported net income was $7.0K in FY2025.
Our AI-assisted moat analysis scores the competitive advantage at 20 out of 100 (low confidence).
What moves the price
The share trades about 28% below its 52-week high and 64% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at −16% fair-value upside, at 27%, UAHC screens cheaper than that median.
Fair Value models
Bear$0.0204Fair Value $0.0229Bull$0.0261
Price $0.0180 · Upside +27.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.60/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+20.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.7%
Revenue growth 28 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.0%
’06
’07
’08
’09
’10
’11
’12
’13
’14
’15
’16
’17
What shareholders gained per year (last 3 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−78.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−78.7%
Dividend (yield on the price)0.0%
Profit margin 2011 to 2017 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.2% → 8%
⚠ Revenue per share shrinking 23.8%/yr over ~12Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+7.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +4.9% a year for the price.
Compare United American Healthcare Corp with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate Services · 472 stocks
Beats the industry median on 6/10 measures
Overall it ranks above its industry peers.
Valuation
Quality Score62 · Above median
Fair Value upside+27.2% · Above median
Profitability
Return on assets0.6% · Below median
Net margin (12 months)−36.8% · Bottom 25%
Operating margin (12 months)7.8% · Below median
Growth and dividend
Revenue growth (quarter YoY)23.3% · Top 25%
Balance sheet
Debt / equity0.01× · Lowest 25%
Valuation Multiplesvs Real Estate Services median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "United American Healthcare Corp Fair Value". https://www.fairvalue-calculator.com/stock/UAHC
Frequently asked questions
Is United American Healthcare Corp (UAHC) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of $0.0229 versus the last price from Oct 29, 2026 of $0.0180, about +27% upside (undervalued).
What is the fair value of UAHC?
Our model-based fair value for United American Healthcare Corp is $0.0229 (as of Nov 7, 2026), built from audited fundamentals. Last price (from Oct 29, 2026): $0.0180.
What is the quality score of UAHC?
United American Healthcare Corp has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for United American Healthcare Corp (UAHC)?
Our model-based price target is the fair value of $0.0229 (as of Nov 7, 2026) from 8 valuation models. Cautious scenario $0.0204, optimistic scenario $0.0261. It is a calculation from audited fundamentals, not an analyst target.
What is the United American Healthcare Corp stock forecast for 2026?
Our models put fair value at $0.0229, about +27% upside versus the last price from Oct 29, 2026 of $0.0180 (undervalued). Cautious scenario $0.0204, optimistic scenario $0.0261. The calculation is refreshed regularly with new filings.
What is the revenue of United American Healthcare Corp (UAHC)?
United American Healthcare Corp reported trailing-twelve-month revenue of about $5.8M (latest available figure, as of Nov 7, 2026).
What growth is priced into United American Healthcare Corp (UAHC)?
For today's price to be fair in a discounted-cash-flow model, United American Healthcare Corp would have to grow free cash flow by +7.4 % per year for five years (discount rate 9.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.7 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of UAHC use?
Our models discount United American Healthcare Corp at 9.7 %: a base by market capitalisation (nano), country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For United American Healthcare Corp that is +7.4 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.7 %) and the same formula as our fair value.
How much growth has United American Healthcare Corp (UAHC) delivered so far?
Over the past 5 years revenue at United American Healthcare Corp grew +4.7 % a year. The price currently implies free-cash-flow growth of +7.4 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of United American Healthcare Corp (UAHC) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into United American Healthcare Corp (+7.4 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of United American Healthcare Corp (UAHC)?
The free-cash-flow yield on the price is 40.81 %: that much free cash flow United American Healthcare Corp produces per unit of market value. When it exceeds the discount rate of our models (9.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of United American Healthcare Corp (UAHC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For United American Healthcare Corp it is $0.0229 per share (as of Nov 7, 2026), against a price of $0.0180. It is the blended result of 8 valuation models in 4 families (DCF Models, Multiples, Growth DCF, Economic Profit).
Is United American Healthcare Corp stock overvalued or undervalued in 2026?
As of Nov 7, 2026, UAHC trades below its calculated fair value: price $0.0180, fair value $0.0229, a gap of about +27% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of UAHC?
No. The price is what the market pays today ($0.0180); the fair value is what the company's own numbers justify ($0.0229). For United American Healthcare Corp the two are $0.0049 per share apart. That gap is exactly why we show both numbers side by side.
How much is United American Healthcare Corp worth?
The market values United American Healthcare Corp at about $2.1M (market capitalisation, as of Nov 7, 2026). Per share that is $0.0180; our models calculate a fair value of $0.0229 per share.
What do the bullish and bearish scenarios say about UAHC?
Our models span a range for United American Healthcare Corp: cautious scenario $0.0204, base $0.0229, optimistic $0.0261 per share (as of Nov 7, 2026, price $0.0180). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of United American Healthcare Corp (UAHC)?
Balance-sheet figures for United American Healthcare Corp (as of Nov 7, 2026): debt of 0.01 per unit of equity. They feed the Quality Score of 62/100, which measures business quality independently of the share price.
How far is UAHC from its 52-week high?
United American Healthcare Corp trades at $0.0180, about 28% below its 52-week high of $0.0250 and 64% above the low of $0.0110 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0229 is for.
Which stocks are comparable to United American Healthcare Corp?
From the same area (Real Estate) we also value CBRE Group, Cellnex Telecom, S.A, KE Holdings, Swire Properties Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is United American Healthcare Corp stock attractive at the current price?
The data as of Nov 7, 2026: price $0.0180, calculated fair value $0.0229 (+27%), Quality Score 62/100, from 8 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of UAHC calculated?
We run United American Healthcare Corp through 8 models from 4 families: DCF Models, Multiples, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of $0.0229 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. United American Healthcare Corp currently trades 21% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of United American Healthcare Corp (UAHC)?
The latest price we hold is from Oct 29, 2026 and stands at $0.0180. Our model-based fair value is $0.0229, about +27% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with United American Healthcare Corp right now?
The price is below even our cautious bear case ($0.0204). The market is more pessimistic than our downside scenario. Solid quality (62/100) at a price below fair value, the discount is the argument here, not the business quality. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Key figures of United American Healthcare Corp
How large is the market capitalisation of United American Healthcare Corp (UAHC)?
The market capitalisation of United American Healthcare Corp is $2.1M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of United American Healthcare Corp (UAHC)?
The price-to-sales ratio of United American Healthcare Corp is 0.36 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of United American Healthcare Corp (UAHC)?
Earnings per share at United American Healthcare Corp are $−0.1800. Earnings per share over the last twelve months: total profit spread across every single share.
What is the EBIT return on assets of United American Healthcare Corp (UAHC)?
On an EBIT basis the return on assets of United American Healthcare Corp is −2.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of United American Healthcare Corp (UAHC)?
The operating margin of United American Healthcare Corp is 7.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at United American Healthcare Corp (UAHC)?
Revenue at United American Healthcare Corp is growing +23.3% versus a year earlier (3y avg +10.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at United American Healthcare Corp (UAHC)?
Earnings per share at United American Healthcare Corp are growing +418% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does United American Healthcare Corp (UAHC) hold?
United American Healthcare Corp holds more cash than debt, $308K net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch United American Healthcare Corp in the live analysis
One click puts United American Healthcare Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 7, 2026